SI vs SN.L
SI: Shoulder Innovations develops orthopedic devices for shoulder and upper extremity conditions, showing explosive revenue growth but facing profitability challenges and dramatic stock depreciation. SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions.
Side-by-side fundamentals
| Metric | SI | SN.L | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $22.06 | £10.74 | |
| Market cap as of 2026-08-24 | $459M | n/a | |
| PEG as of 2026-08-24 | -1.63 | n/a | |
| Net margin as of 2026-08-24 | -17.1% | n/a | |
| Gross margin as of 2026-08-24 | +77.0% | n/a | |
| Operating margin as of 2026-08-24 | -55.4% | n/a | |
| ROE as of 2026-08-24 | -13.6% | n/a | |
| ROA as of 2026-08-24 | -10.9% | n/a | |
| Debt / equity as of 2026-08-24 | 0.11 | n/a | |
| Revenue growth (YoY) as of 2026-08-24 | +151.0% | n/a | |
| Beta as of 2026-08-24 | 13.84 | n/a | |
| 1-year return as of 2026-08-21 close | +80.8% | -22.8% | SI higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.